X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7073) 7073
Book Review (712) 712
Publication (293) 293
Newsletter (262) 262
Magazine Article (33) 33
Newspaper Article (24) 24
Book Chapter (7) 7
Conference Proceeding (7) 7
Dissertation (6) 6
Government Document (1) 1
Paper (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5789) 5789
humans (5268) 5268
female (3403) 3403
male (3349) 3349
amoxicillin (3250) 3250
amoxicillin - administration & dosage (2672) 2672
adult (2251) 2251
middle aged (2011) 2011
anti-bacterial agents - administration & dosage (1859) 1859
amoxicillin - therapeutic use (1841) 1841
anti-bacterial agents - therapeutic use (1667) 1667
helicobacter infections - drug therapy (1500) 1500
drug therapy, combination (1394) 1394
antibiotics (1345) 1345
aged (1341) 1341
treatment outcome (1338) 1338
helicobacter pylori (1248) 1248
pharmacology & pharmacy (1061) 1061
adolescent (927) 927
child (925) 925
gastroenterology & hepatology (869) 869
administration, oral (844) 844
drug administration schedule (840) 840
infection (827) 827
microbiology (807) 807
child, preschool (798) 798
animals (794) 794
clarithromycin - administration & dosage (714) 714
abridged index medicus (689) 689
infectious diseases (685) 685
helicobacter pylori - drug effects (683) 683
prospective studies (640) 640
clarithromycin (634) 634
amoxicillin - adverse effects (607) 607
infant (603) 603
metronidazole - administration & dosage (591) 591
omeprazole - administration & dosage (575) 575
children (561) 561
anti-bacterial agents - adverse effects (549) 549
metronidazole (543) 543
drug therapy (541) 541
dosage and administration (532) 532
time factors (531) 531
eradication (523) 523
microbial sensitivity tests (508) 508
health aspects (501) 501
penicillins - administration & dosage (500) 500
anti-ulcer agents - administration & dosage (492) 492
acute disease (484) 484
anti-bacterial agents - pharmacology (480) 480
pediatrics (478) 478
amoxicillin - pharmacology (460) 460
infections (459) 459
medicine, general & internal (453) 453
clarithromycin - therapeutic use (431) 431
dentistry (430) 430
therapy (430) 430
amoxicillin-potassium clavulanate combination - administration & dosage (427) 427
care and treatment (427) 427
follow-up studies (424) 424
double-blind method (423) 423
amoxicillin-potassium clavulanate combination - therapeutic use (421) 421
management (420) 420
analysis (409) 409
research (403) 403
omeprazole (402) 402
efficacy (401) 401
triple therapy (390) 390
drug therapy, combination - therapeutic use (389) 389
risk factors (389) 389
metronidazole - therapeutic use (385) 385
penicillins - therapeutic use (373) 373
aged, 80 and over (368) 368
clavulanic acid (364) 364
resistance (357) 357
anti-ulcer agents - therapeutic use (346) 346
penicillin (344) 344
lansoprazole (341) 341
helicobacter infections - microbiology (335) 335
diagnosis (333) 333
drugs (327) 327
bacteria (326) 326
pharmacokinetics (324) 324
young adult (324) 324
drug therapy, combination - administration & dosage (323) 323
immunology (323) 323
omeprazole - therapeutic use (320) 320
recurrence (314) 314
dentistry, oral surgery & medicine (313) 313
bacterial infections - drug therapy (311) 311
drug resistance, bacterial (302) 302
amoxicillin - pharmacokinetics (290) 290
otitis media - drug therapy (290) 290
2-pyridinylmethylsulfinylbenzimidazoles (289) 289
helicobacter pylori - isolation & purification (279) 279
helicobacter infections (277) 277
omeprazole - analogs & derivatives (275) 275
surgery (275) 275
dose-response relationship, drug (274) 274
clinical trials (271) 271
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6494) 6494
French (240) 240
Japanese (188) 188
German (131) 131
Spanish (105) 105
Russian (58) 58
Italian (52) 52
Chinese (22) 22
Polish (20) 20
Dutch (15) 15
Bulgarian (9) 9
Korean (9) 9
Czech (7) 7
Hungarian (5) 5
Swedish (5) 5
Turkish (5) 5
Croatian (4) 4
Hebrew (4) 4
Portuguese (4) 4
Romanian (4) 4
Slovak (4) 4
Danish (3) 3
Norwegian (3) 3
Bosnian (2) 2
Afrikaans (1) 1
Finnish (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 09/2016, Volume 65, Issue 9, pp. 1439 - 1446
ObjectiveThe objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a... 
antibiotic therapy | clinical trials | Helicobacter pylori infection | helicobacter pylori - treatment | CLARITHROMYCIN | LANSOPRAZOLE | MULTICENTER | MANAGEMENT | CLINICAL-TRIAL | PHARMACOKINETICS | JAPAN | INFECTION | MONOFUMARATE TAK-438 | GASTROENTEROLOGY & HEPATOLOGY | AMOXICILLIN | Humans | Middle Aged | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Pyrroles - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Peptic Ulcer - diagnosis | Pyrroles - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Sulfonamides - adverse effects | Amoxicillin - adverse effects | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Breath Tests - methods | Peptic Ulcer - etiology | Sulfonamides - administration & dosage | Usage | Safety and security measures | Research | Helicobacter pylori | Antacids | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | CLINICAL TRIALS | 1506 | ANTIBIOTIC THERAPY | HELICOBACTER PYLORI INFECTION
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10058, pp. 2355 - 2365
Summary Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-day triple therapy for the first-line treatment of Helicobacter... 
Internal Medicine | CLARITHROMYCIN | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EFFICACY | GASTRIC-CANCER | RESISTANCE | SEQUENTIAL THERAPY | INFECTION | ERADICATION | METRONIDAZOLE | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Organometallic Compounds - therapeutic use | Female | Urea - metabolism | Amoxicillin - administration & dosage | Lansoprazole - administration & dosage | Drug Administration Schedule | Metronidazole - administration & dosage | Breath Tests | Tetracycline - therapeutic use | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Amoxicillin - therapeutic use | Taiwan | Drug Therapy, Combination - statistics & numerical data | Lansoprazole - therapeutic use | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Organometallic Compounds - administration & dosage | Clinical trials | Medical colleges | Helicobacter infections | Care and treatment | Helicobacter pylori | Antiulcer drugs | Analysis | Bacteria | Bacterial infections | Antibiotics | Drug resistance | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 905 - 913
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9862, pp. 205 - 213
Journal Article
Gastroenterology, ISSN 0016-5085, 10/2018, Volume 155, Issue 4, pp. 1109 - 1119
BACKGROUND & AIMS: We aimed to compare the efficacy of genotypic resistance-guided therapy vs empirical therapy for eradication of refractory Helicobacter... 
Third-Line | Susceptibility Testing | 23S rRNA | Gyrase A | 1ST-LINE TREATMENT | MULTICENTER | METAANALYSIS | RANDOMIZED-TRIAL | SEQUENTIAL THERAPY | OPEN-LABEL | LEVOFLOXACIN | 3RD-LINE TREATMENT | TRIPLE THERAPY | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Predictive Value of Tests | Esomeprazole - administration & dosage | Humans | Middle Aged | Helicobacter pylori - genetics | Helicobacter pylori - pathogenicity | Helicobacter pylori - drug effects | Male | Doxycycline - administration & dosage | Proton Pump Inhibitors - administration & dosage | Time Factors | Clinical Decision-Making | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Bacteriological Techniques | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Drug Resistance, Bacterial - genetics | Drug Therapy, Combination | Levofloxacin - administration & dosage | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Metronidazole - administration & dosage | Breath Tests | Genotype | Treatment Outcome | Taiwan | Aged | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Helicobacter Infections - microbiology | Helicobacter infections | Care and treatment | Helicobacter pylori | Health aspects | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 2016, Volume 32, pp. 84 - 90
Abstract Background Currently only a few studies compare sequential and concomitant non-bismuth Helicobacter pylori therapies referring to high antibiotic... 
Internal Medicine | H. pylori treatment | Sequential treatment | First line | Concomitant treatment | Metronidazole resistance | Clarithromycin resistance | 14-DAY TRIPLE | 1ST-LINE TREATMENT | MULTICENTER | METAANALYSIS | REGIMEN | STANDARD TRIPLE THERAPY | RATES | MEDICINE, GENERAL & INTERNAL | INFECTION | HYBRID THERAPY | DURATION | Esomeprazole - administration & dosage | Humans | Middle Aged | Carbon Isotopes | Drug Resistance, Bacterial | Male | Helicobacter Infections - pathology | Helicobacter pylori | Peptic Ulcer - microbiology | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Helicobacter Infections - metabolism | Urea - metabolism | Amoxicillin - administration & dosage | Drug Therapy, Combination | Dyspepsia - drug therapy | Metronidazole - administration & dosage | Breath Tests | Dyspepsia - microbiology | Pyloric Antrum - pathology | Biopsy | Aged | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Clinical trials | Drug resistance in microorganisms | Clarithromycin | Index Medicus | Helicobacter Infections/drug therapy | Peptic Ulcer/drug therapy | Proton Pump Inhibitors/administration & dosage | Helicobacter Infections/pathology | Peptic Ulcer/microbiology | Tissues and Organs | Life Sciences | Esomeprazole/administration & dosage | Hépatology and Gastroenterology | Pyloric Antrum/pathology | Anti-Bacterial Agents/administration & dosage | Dyspepsia/microbiology | Helicobacter Infections/metabolism | Bacteriology | Clarithromycin/administration & dosage | Urea/metabolism | Metronidazole/administration & dosage | Microbiology and Parasitology | Human health and pathology | Amoxicillin/administration & dosage | Dyspepsia/drug therapy
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9790, pp. 507 - 514
Journal Article